PUBLIC ALERT ON BENYLIN PAEDIATRIC 1OOMLs COUGH SYRUP, BATCH NO. 329304
- Version
- Download 130
- File Size 1.11 MB
- File Count 1
- Create Date June 26, 2024
- Last Updated June 26, 2024
PUBLIC ALERT ON BENYLIN PAEDIATRIC 1OOMLs COUGH SYRUP, BATCH NO. 329304
The Pharmacy and Poisons Board (PPB) wishes to inform the public that it has received information regarding a medical product alert and recall of Benylin pediatric 100mls cough syrup Batch No 329304, by the National Agency for Food and Drug Administration and Control (NAFDAC) of Nigeria. This cough syrup manufactured by Johnson & Johnson (Pty), South Africa, is being recalled due to quality concerns arising from an unacceptable high level of diethylene glycol detected through laboratory analysis conducted by NAFDAC. Diethylene glycol is a contaminant which is toxic to humans when consumed and can prove fatal. Toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.
Attached Files
File | Action |
---|---|
Benylin_Press Statement Medical product alert_Benlyin Paediatic 100mLS.pdf | Download |